Dissecting the complement pathway in hepatic injury and regeneration with a novel protective strategy

Journal of Experimental Medicine

Volumn 211, Issue 9, 2014, Pages 1793-1805

  Marshall, Keely M ^a   He, Songqing ^a,c   Zhong, Zhi ^b   Atkinson, Carl ^a   Tomlinson, Stephen ^a,d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c GUILIN MEDICAL UNIVERSITY   (China)

^d RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT INHIBITOR; COMPLEMENT MEMBRANE ATTACK COMPLEX; CR2 CD59 FUSION PROTEIN; INTERLEUKIN 6; PROTEIN KINASE B; STAT3 PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; CONTROLLED STUDY; LIVER CELL; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; LIVER REGENERATION; LONG TERM SURVIVAL; MEMBRANE DEPOLARIZATION; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, CD59; COMPLEMENT ACTIVATION; COMPLEMENT MEMBRANE ATTACK COMPLEX; CYTOKINES; DISEASE MODELS, ANIMAL; HEPATECTOMY; KINETICS; LIVER; LIVER FAILURE, ACUTE; LIVER REGENERATION; LIVER TRANSPLANTATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA, LIVER; RECEPTORS, COMPLEMENT 3D; RECOMBINANT FUSION PROTEINS; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 84906545577     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20131902     Document Type: Article

References (55)

1. Amsterdam, E.A., G.L. Stahl, H.L. Pan, S.V. Rendig, M.P. Fletcher, and J.C. Longhurst. 1995. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. Am. J. Physiol. 268:H448-H457.
2. Arumugam, T.V., I.A. Shiels, A.J. Strachan, G. Abbenante, D.P. Fairlie, and S.M. Taylor. 2003. A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int. 63:134-142. http://dx.doi.org/10.1046/j.1523-1755.2003.00737.x
3. Arumugam, T.V., T.M. Woodruff, S.Z. Stocks, L.M. Proctor, S. Pollitt, I.A. Shiels, R.C. Reid, D.P. Fairlie, and S.M. Taylor. 2004. Protective effect of a human C5a receptor antagonist against hepatic ischaemiareperfusion injury in rats. J. Hepatol. 40:934-941. http://dx.doi.org/10.1016/j.jhep.2004.02.017
4. Atkinson, C., H. Song, B. Lu, F. Qiao, T.A. Burns, V.M. Holers, G.C. Tsokos, and S. Tomlinson. 2005. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection. J. Clin. Invest. 115:2444-2453. http://dx.doi.org/10.1172/JCI25208
5. Bilzer, M., F. Roggel, and A.L. Gerbes. 2006. Role of Kupffer cells in host defense and liver disease. Liver Int. 26:1175-1186. http://dx.doi.org/10.1111/j.1478-3231.2006.01342.x
6. Blindenbacher, A., X. Wang, I. Langer, R. Savino, L. Terracciano, and M.H. Heim. 2003. Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology. 38:674-682. http://dx.doi.org/10.1053/jhep.2003.50378
7. Breitenstein, S., C. Apestegui, H. Petrowsky, and P.A. Clavien. 2009. "State of the art" in liver resection and living donor liver transplantation: a worldwide survey of 100 liver centers. World J. Surg. 33:797-803. http://dx.doi.org/10.1007/s00268-008-9878-0
8. Clavien, P.A., H. Petrowsky, M.L. DeOliveira, and R. Graf. 2007. Strategies for safer liver surgery and partial liver transplantation. N. Engl. J. Med. 356:1545-1559. http://dx.doi.org/10.1056/NEJMra065156
9. Cressman, D.E., L.E. Greenbaum, R.A. DeAngelis, G. Ciliberto, E.E. Furth, V. Poli, and R. Taub. 1996. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 274:1379-1383. http://dx.doi.org/10.1126/science.274.5291.1379
10. Di Santo, E., T. Alonzi, V. Poli, E. Fattori, C. Toniatti, M. Sironi, P. Ricciardi-Castagnoli, and P. Ghezzi. 1997. Differential effects of IL-6 on systemic and central production of TNF: a study with IL-6-deficient mice. Cytokine. 9:300-306. http://dx.doi.org/10.1006/cyto.1996.0169
11. Diepenhorst, G.M., T.M. van Gulik, and C.E. Hack. 2009. Complementmediated ischemia-reperfusion injury: lessons learned from animal and clinical studies. Ann. Surg. 249:889-899. http://dx.doi.org/10.1097/SLA.0b013e3181a38f45
12. Dixon, E., C.M. Vollmer Jr., O.F. Bathe, and F. Sutherland. 2005. Vascular occlusion to decrease blood loss during hepatic resection. Am. J. Surg. 190:75-86. http://dx.doi.org/10.1016/j.amjsurg.2004.10.007
13. Evans, Z.P., J.D. Ellett, M.G. Schmidt, R.G. Schnellmann, and K.D. Chavin. 2008. Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion. J. Biol. Chem. 283:8573-8579. http://dx.doi.org/10.1074/jbc. M706784200
14. Fondevila, C., X.D. Shen, S. Tsuchihashi, Y. Uchida, M.C. Freitas, B. Ke, R.W. Busuttil, and J.W. Kupiec-Weglinski. 2008. The membrane attack complex (C5b-9) in liver cold ischemia and reperfusion injury. Liver Transpl. 14:1133-1141. http://dx.doi.org/10.1002/lt.21496
15. Garcea, G., and G.J. Maddern. 2009. Liver failure after major hepatic resection. J. Hepatobiliary Pancreat. Surg. 16:145-155. http://dx.doi.org/10.1007/s00534-008-0017-y
16. Greene, A.K., and M. Puder. 2003. Partial hepatectomy in the mouse: technique and perioperative management. J. Invest. Surg. 16:99-102. http://dx.doi.org/10.1080/08941930390194424
17. Hattori, R., K.K. Hamilton, R.P. McEver, and P.J. Sims. 1989. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J. Biol. Chem. 264:9053-9060.
18. He, S., C. Atkinson, F. Qiao, K. Cianflone, X. Chen, and S. Tomlinson. 2009. A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice. J. Clin. Invest. 119: 2304-2316.
19. Helling, T.S. 2006. Liver failure following partial hepatectomy. HPB (Oxford). 8:165-174. http://dx.doi.org/10.1080/13651820510035712
20. Holt, D.S., M. Botto, A.E. Bygrave, S.M. Hanna, M.J. Walport, and B.P. Morgan. 2001. Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood. 98:442-449. http://dx.doi.org/10.1182/blood. V98.2.442
21. Huang, Y., F. Qiao, C. Atkinson, V.M. Holers, and S. Tomlinson. 2008. A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury. J. Immunol. 181:8068-8076. http://dx.doi.org/10.4049/jimmunol.181.11.8068
22. Huang, H., H.W. Chen, J. Evankovich, W. Yan, B.R. Rosborough, G.W. Nace, Q. Ding, P. Loughran, D. Beer-Stolz, T.R. Billiar, et al. 2013. Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury. J. Immunol. 191:2665-2679. http://dx.doi.org/10.4049/jimmunol.1202733
23. Kilgore, K.S., E. Schmid, T.P. Shanley, C.M. Flory, V. Maheswari, N.L. Tramontini, H. Cohen, P.A. Ward, H.P. Friedl, and J.S. Warren. 1997. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-κB activation. Am. J. Pathol. 150:2019-2031.
24. Kilgore, K.S., J.L. Park, E.J. Tanhehco, E.A. Booth, R.M. Marks, and B.R. Lucchesi. 1998. Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusion. J. Mol. Cell. Cardiol. 30:75-85. http://dx.doi.org/10.1006/jmcc.1997.0573
25. Kim, G.H., J. Mocco, D.K. Hahn, C.P. Kellner, R.J. Komotar, A.F. Ducruet, W.J. Mack, and E.S. Connolly Jr. 2008. Protective effect of C5a receptor inhibition after murine reperfused stroke. Neurosurgery. 63:122-126. http://dx.doi.org/10.1227/01.NEU.0000335079.70222.8D
26. Kimberley, F.C., B. Sivasankar, and B. Paul Morgan. 2007. Alternative roles for CD59. Mol. Immunol. 44:73-81. http://dx.doi.org/10.1016/j.molimm.2006.06.019
27. Kwan, W.H., W. van der Touw, E. Paz-Artal, M.O. Li, and P.S. Heeger. 2013. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J. Exp. Med. 210:257-268. http://dx.doi.org/10.1084/jem.20121525
28. Lewis, A.G., G. Köhl, Q. Ma, P. Devarajan, and J. Köhl. 2008. Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival. Clin. Exp. Immunol. 153:117-126. http://dx.doi.org/10.1111/j.1365-2249.2008.03678.x
29. Li, W., X. Liang, C. Kellendonk, V. Poli, and R. Taub. 2002. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J. Biol. Chem. 277:28411-28417. http://dx.doi.org/10.1074/jbc. M202807200
30. Markiewski, M.M., R.A. DeAngelis, C.W. Strey, P.G. Foukas, C. Gerard, N. Gerard, R.A. Wetsel, and J.D. Lambris. 2009. The regulation of liver cell survival by complement. J. Immunol. 182:5412-5418. http://dx.doi.org/10.4049/jimmunol.0804179
31. Mastellos, D., J.C. Papadimitriou, S. Franchini, P.A. Tsonis, and J.D. Lambris. 2001. A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J. Immunol. 166:2479-2486. http://dx.doi.org/10.4049/jimmunol.166.4.2479
32. Moseley, E.L., C. Atkinson, L.D. Sharples, J. Wallwork, and M.J. Goddard. 2010. Deposition of C4d and C3d in cardiac transplants: a factor in the development of coronary artery vasculopathy. J. Heart Lung Transplant. 29:417-423. http://dx.doi.org/10.1016/j.healun.2009.12.018
33. Papadimitriou, J.C., L.E. Ramm, C.B. Drachenberg, B.F. Trump, and M.L. Shin. 1991. Quantitative analysis of adenine nucleotides during the prelytic phase of cell death mediated by C5b-9. J. Immunol. 147:212-217.
34. Rehman, H., J. Sun, Y. Shi, V.K. Ramshesh, Q. Liu, R.T. Currin, J.J. Lemasters, and Z. Zhong. 2011. NIM811 prevents mitochondrial dysfunction, attenuates liver injury, and stimulates liver regeneration after massive hepatectomy. Transplantation. 91:406-412.
35. Rus, H.G., F.I. Niculescu, and M.L. Shin. 2001. Role of the C5b-9 complement complex in cell cycle and apoptosis. Immunol. Rev. 180:49-55. http://dx.doi.org/10.1034/j.1600-065X.2001.1800104.x
36. Scolding, N.J., W.A. Houston, B.P. Morgan, A.K. Campbell, and D.A. Compston. 1989. Reversible injury of cultured rat oligodendrocytes by complement. Immunology. 67:441-446.
37. Sekine, H., T.T. Kinser, F. Qiao, E. Martinez, E. Paulling, P. Ruiz, G.S. Gilkeson, and S. Tomlinson. 2011. The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice. Arthritis Rheum. 63:1076-1085. http://dx.doi.org/10.1002/art.30222
38. Sharkey, R.M., A. Natale, D.M. Goldenberg, and M.J. Mattes. 1991. Rapid blood clearance of immunoglobulin G2a and immunoglobulin G2b in nude mice. Cancer Res. 51:3102-3107.
39. Sigala, F., G. Kostopanagiotou, I. Andreadou, N. Kavatzas, E. Felekouras, P. Sigalas, E. Bastounis, and E. Papalambros. 2004. Histological and lipid peroxidation changes after administration of 2-acetylaminofluorene in a rat liver injury model following selective periportal and pericentral damage. Toxicology. 196:155-163. http://dx.doi.org/10.1016/j.tox.2003.12.005
40. Singhal, R., P.E. Ganey, and R.A. Roth. 2012. Complement activation in acetaminophen-induced liver injury in mice. J. Pharmacol. Exp. Ther. 341:377-385. http://dx.doi.org/10.1124/jpet.111.189837
41. Song, H., C. He, C. Knaak, J.M. Guthridge, V.M. Holers, and S. Tomlinson. 2003. Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation. J. Clin. Invest. 111:1875-1885. http://dx.doi.org/10.1172/JCI17348
42. Strey, C.W., M. Markiewski, D. Mastellos, R. Tudoran, L.A. Spruce, L.E. Greenbaum, and J.D. Lambris. 2003. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J. Exp. Med. 198:913-923. http://dx.doi.org/10.1084/jem.20030374
43. Taub, R. 2004. Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 5:836-847. http://dx.doi.org/10.1038/nrm1489
44. Tegla, C.A., C. Cudrici, S. Patel, R. Trippe III, V. Rus, F. Niculescu, and H. Rus. 2011. Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunol. Res. 51:45-60. http://dx.doi.org/10.1007/s12026-011-8239-5
45. Topp, S.A., G.A. Upadhya, and S.M. Strasberg. 2004. Cold preservation of isolated sinusoidal endothelial cells in MMP 9 knockout mice: effect on morphology and platelet adhesion. Liver Transpl. 10:1041-1048. http://dx.doi.org/10.1002/lt.20216
46. Tramontini, N.L., P.J. Kuipers, C.M. Huber, K. Murphy, K.B. Naylor, A.J. Broady, and K.S. Kilgore. 2002. Modulation of leukocyte recruitment and IL-8 expression by the membrane attack complex of complement (C5b-9) in a rabbit model of antigen-induced arthritis. Inflammation. 26:311-319. http://dx.doi.org/10.1023/A:1021420903355
47. Triantafilou, K., T.R. Hughes, M. Triantafilou, and B.P. Morgan. 2013. The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation. J. Cell Sci. 126:2903-2913. http://dx.doi.org/10.1242/jcs.124388
48. Tuñón, M.J., M. Alvarez, J.M. Culebras, and J. González-Gallego. 2009. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J. Gastroenterol. 15:3086-3098. http://dx.doi.org/10.3748/wjg.15.3086
49. Wang, H., S.A. Rollins, Z. Gao, B. Garcia, Z. Zhang, J. Xing, L. Li, R. Kellersmann, L.A. Matis, and R. Zhong. 1999. Complement inhibition with an anti-C5 monoclonal antibody prevents hyperacute rejection in a xenograft heart transplantation model. Transplantation. 68:1643-1651. http://dx.doi.org/10.1097/00007890-199912150-00007
50. Yamada, Y., I. Kirillova, J.J. Peschon, and N. Fausto. 1997. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. USA. 94:1441-1446. http://dx.doi.org/10.1073/pnas.94.4.1441
51. Zhang, H.F., J. Yu, E. Bajwa, S.L. Morrison, and S. Tomlinson. 1999. Targeting of functional antibody-CD59 fusion proteins to a cell surface. J. Clin. Invest. 103:55-61. http://dx.doi.org/10.1172/JCI4607
52. Zhang, J., W. Hu, W. Xing, T. You, J. Xu, X. Qin, and Z. Peng. 2011. The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury. Am. J. Pathol. 179:2876-2884. http://dx.doi.org/10.1016/j.ajpath.2011.08.040
53. Zheng, X., X. Zhang, B. Feng, H. Sun, M. Suzuki, T. Ichim, N. Kubo, A. Wong, L.R. Min, M.E. Budohn, et al. 2008. Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury. Am. J. Pathol. 173:973-980. http://dx.doi.org/10.2353/ajpath.2008.080103
54. Zhong, Z., R.F. Schwabe, Y. Kai, L. He, L. Yang, H. Bunzendahl, D.A. Brenner, and J.J. Lemasters. 2006. Liver regeneration is suppressed in small-for-size liver grafts after transplantation: involvement of c-Jun N-terminal kinase, cyclin D1, and defective energy supply. Transplantation. 82:241-250. http://dx.doi.org/10.1097/01.tp.0000228867.98158.d2
55. Zhong, Z., V.K. Ramshesh, H. Rehman, R.T. Currin, V. Sridharan, T.P. Theruvath, I. Kim, G.L. Wright, and J.J. Lemasters. 2008. Activation of the oxygen-sensing signal cascade prevents mitochondrial injury after mouse liver ischemia-reperfusion. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G823-G832. http://dx.doi.org/10.1152/ajpgi.90287.2008